Aluminum Granuloma After Administration of the Quadrivalent Human Papillomavirus Vaccine. Report of a Case

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
The American Journal of dermatopathology (Impact Factor: 1.39). 01/2009; 30(6):622-4. DOI: 10.1097/DAD.0b013e318185a691
Source: PubMed


We report the case of a young woman who developed a subcutaneous granulomatous response after administration of the quadrivalent human papillomavirus vaccine. The inciting agent was most likely an aluminum adjuvant, which previously has been reported to be associated with a granulomatous response after administration of other vaccines. Histologically, the lesion consisted of a necrotic/necrobiotic center surrounded by palisading epithelioid histiocytes closely resembling deep granuloma annulare or rheumatoid nodule. The histiocytes contained abundant intracytoplasmic violaceous/gray granular material. An ammonium aurintricarboxylate (Aluminon) stain demonstrated the presence of aluminum in the granular material. Aluminum granulomas should be included in the differential diagnosis of deep granulomatous reaction in young women, due to the high frequency of vaccination in this population.

16 Reads
  • Source
    • "Case reports of injected aluminium in a tattoo or cosmetic eyebrows have been described (32, 33). Histopathological examination of the nodules has shown granuloma formations in which aluminium can be shown by staining and atomic absorption spectrometry (5, 6, 34). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. In studies in Gothenburg, Sweden, in the 1990s of an aluminium hydroxide-adsorbed pertussis toxoid vaccine, 745 of ∼76 000 vaccinated children developed long-lasting itchy subcutaneous nodules at the vaccination site. Of 495 children with itchy nodules patch tested for aluminium allergy, 376 (76%) were positive. Objectives. To study the prognosis of the vaccine-induced aluminium allergy. Patients and methods. Two hundred and forty-one children with demonstrated aluminium allergy in the previous study were patch tested again 5–9 years after the initial test, with the same procedure as used previously. Results. Contact allergy to aluminium was no longer demonstrable in 186 of the retested 241 children (77%). A negative test result was more common in children who no longer had itching at the vaccination site; it was also related to the age of the child, the time after the first aluminium-adsorbed vaccine dose, and the strength of the reaction in the first test. Conclusions. Patch test reactivity to aluminium seems to disappear or weaken with time.
    Contact Dermatitis 05/2013; 68(5):286-92. DOI:10.1111/cod.12053 · 3.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Necrobiosis refers to the degeneration of collagen fibres which is central to necrobiotic dermatitides. We describe these necrobiotic dermatitides; namely granuloma annulare, rheumatoid nodule, necrobiosis lipoidica and necrobiosis xanthogranuloma with an approach to diagnosis, clinical presentation and treatment options. In most instances, the diagnosis can be easily reached; however, at times this can be difficult and may require additional steps, including detailed clinical history, special stains, immunohistochemical stains and a repeat biopsy if necessary.
    Diagnostic Histopathology 04/2009; 15(4):186-194. DOI:10.1016/j.mpdhp.2009.02.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite the advent of the Papanicolaou smear test almost 50 years ago, cervical cancer remains the second most common malignant disease in women and the leading cause of cancer death in developing countries. Thus the two prophylactic human papillomavirus (HPV) vaccines currently available have been greeted with enthusiasm internationally, as an emerging primary prevention strategy against cervical cancer. Prior to licensure the vaccines were trialed in over 60,000 women and assessed as safe, within the statistical constraints of the trials to detect very rare events. Post-licensure surveillance is underway as vaccination programs are undertaken. We reviewed published post-licensure surveillance data, as at January 2009, and concur with international advisory bodies that both HPV vaccines are safe, effective and of great importance for women's health. Ongoing monitoring is required to maintain confidence in the safety of the vaccines.
    Vaccine 09/2009; 27(52):7270-81. DOI:10.1016/j.vaccine.2009.09.097 · 3.62 Impact Factor
Show more